GO:0016153 urocanate hydratase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016153 defines urocanate hydratase activity, the enzyme that catalyzes the reversible hydration of trans-urocanate to 4-imidazolone-5-propanoate in the histidine degradation pathway.
• Urocanate hydratase (EC 4.2.1.49) is a key enzyme in the histidine catabolic route, converting urocanate to imidazolone propionate, which is further metabolized to glutamate.
• The enzyme is widely distributed in bacteria, plants, and animals, and its deficiency in humans is associated with liver urocanase deficiency, a rare metabolic disorder.
• Structural studies reveal that urocanase from Pseudomonas putida is a homodimer with a TIM-barrel fold and requires NAD+ as a cofactor for catalysis.
• Urocanate hydratase activity is essential for histidine utilization and has been targeted in microbiome studies as a potential biomarker for peri-implantitis.
• Research on urocanate hydratase activity employs knockout, point mutation, and overexpression models to dissect its role in metabolism and disease.
Description
Urocanate hydratase activity (GO:0016153) is a molecular function that catalyzes the reversible hydration of trans-urocanate to 4-imidazolone-5-propanoate, a critical step in the histidine degradation pathway. This enzymatic activity is essential for the catabolism of L-histidine, allowing organisms to utilize histidine as a carbon and nitrogen source. The enzyme, also known as urocanase, is found across all domains of life and has been extensively studied for its catalytic mechanism and structural properties. In humans, urocanate hydratase deficiency can lead to metabolic abnormalities, highlighting its physiological importance. Recent research has also linked urocanate hydratase activity to microbial communities and disease states, such as peri-implantitis, underscoring its broader relevance. Understanding this activity at the molecular level provides insights into amino acid metabolism and potential therapeutic targets.
urocanate hydratase activity At A Glance
| GO ID | GO:0016153 |
|---|---|
| GO term | urocanate hydratase activity |
| Ontology | molecular_function |
| Synonym | urocanase activity; imidazolonepropionate hydrolase activity; 3-(5-oxo-4,5-dihydro-3H-imidazol-4-yl)propanoate hydro-lyase activity |
| Major function | Catalyzes the reversible hydration of trans-urocanate to 4-imidazolone-5-propanoate in histidine degradation |
| EC number | 4.2.1.49 |
| Cofactor | NAD+ (in some organisms) |
| Pathway | L-histidine degradation |
| Subcellular location | Cytoplasm (in bacteria and animals) |
What Is GO:0016153?
Urocanate hydratase activity (GO:0016153) is defined as the catalysis of the reaction: 4-imidazolone-5-propanoate + H+ = trans-urocanate + H2O. This reversible hydration reaction is a key step in the histidine catabolic pathway, where trans-urocanate is converted to 4-imidazolone-5-propanoate, which is subsequently hydrolyzed to formiminoglutamate and then to glutamate.
Why Is urocanate hydratase activity Important in Cell Biology?
Urocanate hydratase activity is crucial for the efficient breakdown of L-histidine, an amino acid involved in numerous physiological processes, including neurotransmitter synthesis and immune function. Defects in this enzyme can lead to the accumulation of urocanate, which has been associated with liver urocanase deficiency and potential neurological symptoms. Moreover, the enzyme is a target for antimicrobial drug development because many pathogenic bacteria rely on histidine degradation for survival. In biotechnology, urocanate hydratase is used in biosensors for L-histidine detection. Its role in the microbiome further underscores its importance in host-microbe interactions and disease.
• Essential for L-histidine catabolism, providing carbon and nitrogen sources for many organisms.
• Deficiency in humans causes liver urocanase deficiency, a rare metabolic disorder with clinical implications.
• Serves as a model enzyme for studying reversible hydration reactions and cofactor-dependent catalysis.
• Potential biomarker for peri-implantitis, as revealed by microbiome and metatranscriptome analyses.
• Target for antibacterial drug discovery due to its role in bacterial histidine utilization.
• Used in biosensors for L-histidine determination in clinical and food samples.
• Involved in ergothioneine catabolism in bacteria, expanding its metabolic roles.
• Structural and mechanistic studies inform enzyme engineering and inhibitor design.
Molecular Mechanism of urocanate hydratase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs urocanate and adds water to it, turning it into a different molecule.
Urocanate hydratase binds trans-urocanate and catalyzes the addition of water across the double bond, forming 4-imidazolone-5-propanoate. This reversible hydration is essential for histidine degradation. The reaction proceeds via a mechanism involving a conserved glutamate residue as a general acid-base catalyst, and in some organisms, NAD+ acts as an electron sink to facilitate the reaction.
Cofactor Requirements
In simple terms: Some versions of the enzyme need a helper molecule called NAD+ to work.
In Pseudomonas putida, urocanase is a homodimer that binds one NAD+ per monomer. The NAD+ is not used for redox chemistry but rather to stabilize the transition state during catalysis. Other organisms may use different cofactors or none, as seen in S-methyl thiourocanate hydratase, which is structurally related but has distinct substrate specificity.
Structural Features
In simple terms: The enzyme has a barrel-like shape that holds the active site.
Crystal structures of urocanase from P. putida reveal a TIM-barrel fold with the active site located at the C-terminal end of the barrel. The enzyme functions as a dimer, and dimerization is essential for activity. The structure provides insights into substrate specificity and catalytic mechanism, aiding inhibitor design.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be turned on or off depending on the cell's needs.
Urocanate hydratase activity is regulated at the transcriptional level in response to histidine availability. In bacteria, the hut operon, which includes urocanase, is induced by histidine and repressed by glucose. In humans, enzyme levels may be affected by metabolic states, but specific regulatory mechanisms are less understood.
Key Genes Involved in GO:0016153 urocanate hydratase activity
The following genes and proteins are directly involved in urocanate hydratase activity or its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| hutU | Encodes urocanate hydratase in bacteria | Model for histidine utilization and enzyme mechanism |
| UROC1 | Human gene encoding urocanate hydratase | Mutations cause urocanase deficiency |
| hutH | Histidine ammonia-lyase, upstream of urocanase | Produces urocanate for urocanase |
| hutI | Imidazolonepropionase, downstream of urocanase | Completes histidine degradation |
| hutG | Formiminoglutamase, downstream of urocanase | Further metabolizes histidine |
| hutC | Transcriptional regulator of hut operon | Regulates urocanase expression |
| hutF | Formiminoglutamate deiminase, alternative route | Bypasses urocanase in some bacteria |
| hutD | Histidine permease | Uptake of histidine for degradation |
| hutE | Histidine transaminase | Alternative histidine degradation |
| hutM | Urocanate hydratase in some species | Variant enzyme with similar function |
| egtE | S-methyl thiourocanate hydratase | Ergothioneine catabolism, structurally related |
| egtC | Ergothioneine catabolism enzyme | Pathway involving urocanate-like intermediates |
| hisD | Histidinol dehydrogenase, histidine biosynthesis | Opposite pathway to degradation |
| hisC | Histidinol-phosphate aminotransferase | Histidine biosynthesis |
| hisB | Imidazoleglycerol-phosphate dehydratase | Histidine biosynthesis |
| hisH | Amidotransferase | Histidine biosynthesis |
| hisF | Cyclase | Histidine biosynthesis |
How Is urocanate hydratase activity Regulated?
Urocanate hydratase activity is primarily regulated at the genetic level. In bacteria, the hut operon (hutU, hutH, hutI, hutG) is induced by L-histidine and subject to catabolite repression by glucose. The hutC gene encodes a repressor that binds to the hut operon in the absence of histidine. In humans, UROC1 expression may be influenced by metabolic and hormonal factors, but detailed regulatory mechanisms remain to be elucidated. Additionally, post-translational modifications could affect enzyme activity, though evidence is limited.
urocanate hydratase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UROC1 | Urocanase deficiency | UROC1 knockout mouse or patient-derived fibroblasts |
| hutU | Bacterial histidine utilization | hutU deletion in Pseudomonas putida |
| egtE | Ergothioneine catabolism | egtE knockout in Mycobacterium smegmatis |
| hutU (microbiome) | Peri-implantitis | Oral microbiome metatranscriptomics |
| UROC1 | Liver dysfunction | Liver-specific UROC1 knockout mouse |
Urocanase Deficiency
Urocanase deficiency is a rare autosomal recessive metabolic disorder caused by mutations in the UROC1 gene, leading to reduced urocanate hydratase activity. Patients may present with elevated urocanate levels in urine and plasma, and symptoms can include intellectual disability, seizures, and liver dysfunction. The condition is diagnosed by measuring enzyme activity in liver biopsies or by genetic testing.
Peri-implantitis
Recent microbiome and metatranscriptome analyses have identified urocanate hydratase as a potential diagnostic biomarker for peri-implantitis, an inflammatory disease affecting dental implants. The enzyme's activity in oral microbial communities may contribute to disease pathogenesis by altering histidine metabolism and host-microbe interactions.
Bacterial Infections
Many pathogenic bacteria, such as Pseudomonas and Klebsiella species, rely on urocanate hydratase for histidine utilization during infection. Inhibiting this enzyme could attenuate bacterial growth and virulence, making it a target for novel antibiotics.
From urocanate hydratase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of urocanase? | Point mutations in hutU (e.g., active site residues) |
| How does urocanase deficiency affect metabolism? | UROC1 knockout mouse or cell lines |
| Can urocanase inhibitors be developed as antibiotics? | Knockout of hutU in pathogenic bacteria |
| What is the role of urocanase in ergothioneine catabolism? | egtE knockout in M. smegmatis |
| How does urocanase contribute to peri-implantitis? | Overexpression in oral bacteria or metatranscriptomics |
| Can urocanase be used for L-histidine biosensing? | Engineered urocanase with fluorescent tags |
How to Study the urocanate hydratase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| UV spectrophotometry | Urocanate consumption at 277 nm | Enzyme kinetics and inhibitor screening |
| X-ray crystallography | Three-dimensional structure | Active site analysis and drug design |
| Site-directed mutagenesis | Effect of specific residues on activity | Mechanistic studies |
| Knockout models | Loss of enzyme function in vivo | Metabolic and disease studies |
| Metabolomics | Levels of urocanate and downstream metabolites | Diagnosis of urocanase deficiency |
| Metatranscriptomics | Expression of urocanate hydratase in microbial communities | Biomarker discovery |
| Enzyme-linked immunosorbent assay | Protein levels of urocanase | Clinical diagnostics |
| Biosensor development | L-histidine detection | Food and clinical analysis |
Enzymatic Assays
Urocanate hydratase activity is typically measured spectrophotometrically by monitoring the decrease in absorbance at 277 nm as urocanate is converted to 4-imidazolone-5-propanoate. This assay is used to determine kinetic parameters and to screen for inhibitors.
Structural Biology
X-ray crystallography and cryo-electron microscopy have been used to solve the structure of urocanase from Pseudomonas putida, revealing a TIM-barrel fold and NAD+ binding site. These methods are essential for understanding substrate specificity and designing inhibitors.
Genetic Knockouts
Knockout models, such as hutU deletion in bacteria or UROC1 knockout mice, are used to study the physiological consequences of loss of urocanate hydratase activity. These models help link enzyme function to metabolic pathways and disease.
Metabolomics and Flux Analysis
Metabolomic profiling of histidine degradation intermediates, such as urocanate and formiminoglutamate, can assess urocanate hydratase activity in cells and tissues. Isotope tracing can quantify flux through the pathway.
How CRISPR Can Be Used to Study GO:0016153 urocanate hydratase activity
Knockout
CRISPR-Cas9 knockout of UROC1 or hutU can create cell and animal models to study urocanate hydratase deficiency. These models exhibit elevated urocanate levels and can be used to test therapeutic interventions.
Point Mutation
Introducing point mutations in the active site of urocanate hydratase (e.g., glutamate residues) via CRISPR can dissect catalytic mechanism and identify essential residues. Such models help validate structural findings.
Knock-in
Knock-in of tagged urocanate hydratase (e.g., GFP or FLAG) allows real-time tracking of enzyme localization and interaction partners in live cells. This is useful for studying its subcellular distribution and dynamics.
Overexpression
CRISPR activation (CRISPRa) or plasmid-based overexpression of urocanate hydratase can increase flux through the histidine degradation pathway, enabling metabolic engineering and biosensor development.
How EDITGENE Supports urocanate hydratase activity Research
Researchers studying urocanate hydratase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways or disease. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for urocanate hydratase activity research.
Frequently Asked Questions About urocanate hydratase activity
What is urocanate hydratase activity?
Urocanate hydratase activity (GO:0016153) is the enzymatic catalysis of the reversible hydration of trans-urocanate to 4-imidazolone-5-propanoate, a step in histidine degradation.
What genes are involved in urocanate hydratase activity?
Key genes include UROC1 in humans, hutU in bacteria, and egtE in ergothioneine catabolism.
What diseases are associated with urocanate hydratase deficiency?
Urocanase deficiency, a rare metabolic disorder, and peri-implantitis have been linked to altered urocanate hydratase activity.
How is urocanate hydratase activity measured?
It is commonly measured by a spectrophotometric assay monitoring urocanate consumption at 277 nm.
What is the structure of urocanate hydratase?
The enzyme typically forms a homodimer with a TIM-barrel fold and may bind NAD+ as a cofactor.
Can urocanate hydratase be targeted for antibiotics?
Yes, inhibiting bacterial urocanate hydratase could block histidine utilization and attenuate pathogens.
What is the role of urocanate hydratase in histidine metabolism?
It converts urocanate to imidazolone propionate, which is further metabolized to glutamate, providing carbon and nitrogen.
How do CRISPR models help study urocanate hydratase?
CRISPR knockout, point mutation, and overexpression models allow functional dissection of the enzyme in metabolism and disease.
Is urocanate hydratase found in humans?
Yes, the human UROC1 gene encodes urocanate hydratase, and its deficiency causes a metabolic disorder.
What are the synonyms for urocanate hydratase activity?
Synonyms include urocanase activity, imidazolonepropionate hydrolase activity, and 3-(5-oxo-4,5-dihydro-3H-imidazol-4-yl)propanoate hydro-lyase activity.
Conclusion
Urocanate hydratase activity (GO:0016153) is a fundamental enzymatic function in histidine catabolism with broad implications for metabolism, disease, and biotechnology. Structural and mechanistic studies have elucidated its catalytic strategy, while genetic and microbiome research has linked it to human disorders such as urocanase deficiency and peri-implantitis. The availability of CRISPR tools and EDITGENE's services empowers researchers to further explore this enzyme's roles and develop targeted interventions.
References
- 1. Joshi AA et al.. 2025. Integrative microbiome- and metatranscriptome-based analyses reveal diagnostic biomarkers for peri-implantitis.. NPJ Biofilms Microbiomes 11(1):175 PMID: 40858628
- 2. Cohn MS et al.. 1975. Catalytic and thermodynamic properties of the urocanate hydratase reaction.. Biochim Biophys Acta 377(2):444-53 PMID: 235308
- 3. Vasseur CM et al.. 2024. Structure and Substrate Specificity of S-Methyl Thiourocanate Hydratase.. ACS Chem Biol 19(3):718-724 PMID: 38389448
- 4. Kessler D et al.. 2004. Structure and action of urocanase.. J Mol Biol 342(1):183-94 PMID: 15313616
- 5. Kalafatic Z et al.. 1980. A liver urocanase deficiency.. Metabolism 29(11):1013-9 PMID: 6107814
- 6. Matsui D et al.. 2021. Identification of l-histidine oxidase activity in Achromobacter sp. TPU 5009 for l-histidine determination.. J Biosci Bioeng 131(5):469-474 PMID: 33487551
- 7. Coote JG et al.. 1973. The degradation of L-histidine, imidazolyl-L-lactate and imidazolylpropionate by Pseudomonas testosteroni.. Biochem J 132(3):409-22 PMID: 4146796
- 8. Beliaeva MA et al.. 2021. In Vitro Reconstitution of a Five-Step Pathway for Bacterial Ergothioneine Catabolism.. ACS Chem Biol 16(2):397-403 PMID: 33544568
